在影像诊断领域的联盟:2014年~2020年的全球的契约条件
市场调查报告书
商品编码
939921

在影像诊断领域的联盟:2014年~2020年的全球的契约条件

Diagnostic Imaging Collaboration and Licensing Deals 2016-2023

出版日期: | 出版商: Current Partnering | 英文 300+ Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告提供从2014年开到2020年的全球影像诊断领域的联盟调查,提供契约缔结的趋势,财务方面的条件,主要的契约相关组织,契约文件的要览,各技术类型的契约等资讯。

目录

摘要整理

第1章 - 简介

第2章 -契约的趋势

  • 简介
  • 长期性的联盟
  • 有活跃的动向的厂商
  • 各类型契约的联盟
  • 各治疗领域的联盟
  • 契约条件
    • 主要的金额
    • 领先付款
    • 里程碑付款
    • 许可证费用

第3章 -主要的契约

  • 简介
  • 金额的大的契约

第4章 -有活跃的动向的组织

  • 简介
  • 针对契约活跃的组织
  • 对联盟积极的企业的简介

第5章 -契约文件要览

  • 简介
  • 契约文件要览

第6章 -各技术类型的契约

第7章 合作资源中心

  • 网路伙伴合作
  • 合作伙伴活动
  • 契约缔结相关资料

附录

简介目录
Product Code: CP21041

Description

Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the diagnostic imaging deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of diagnostic imaging deals from 2016 to 2023.

The report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 567 diagnostic imaging deals announced since 2016 including financial terms where available including links to online deal records of actual diagnostic imaging partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of diagnostic imaging dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in diagnostic imaging dealmaking since 2016.

Chapter 3 provides an overview of the leading diagnostic imaging deals since 2016. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in diagnostic imaging dealmaking with a brief summary followed by a comprehensive listing of diagnostic imaging deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of diagnostic imaging deals signed and announced since Jan 2016, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of diagnostic imaging partnering deals signed and announced since Jan 2016. The chapter is organized by specific diagnostic imaging technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in diagnostic imaging deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse diagnostic imaging collaboration and licensing deals
  • Benchmark analysis - identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, deal type and therapy area
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Report scope

  • Diagnostic Imaging Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of diagnostic imaging trends and structure of deals entered into by leading biopharma companies worldwide.

Diagnostic Imaging Collaboration and Licensing Deals includes:

  • Trends in diagnostic imaging dealmaking in the biopharma industry
  • Directory of diagnostic imaging deal records covering pharmaceutical and biotechnology
  • The leading diagnostic imaging deals by value
  • Most active diagnostic imaging licensing dealmakers
  • Diagnostic Imaging Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2016
  • Browse diagnostic imaging collaboration and licensing deals
  • Benchmark analysis - identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, deal type and therapy area
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in diagnostic imaging dealmaking

  • 2.1. Introduction
  • 2.2. Diagnostic imaging deals over the years
  • 2.3. Most active diagnostic imaging dealmakers
  • 2.4. Diagnostic imaging deals by deal type
  • 2.5. Diagnostic imaging deals by therapy area
  • 2.6. Diagnostic imaging deals by industry sector
  • 2.7. Deal terms for diagnostic imaging deals
    • 2.7.1 Diagnostic imaging deals headline values
    • 2.7.2 Diagnostic imaging deal upfront payments
    • 2.7.3 Diagnostic imaging deal milestone payments
    • 2.7.4 Diagnostic imaging royalty rates

Chapter 3 - Leading diagnostic imaging deals

  • 3.1. Introduction
  • 3.2. Top diagnostic imaging deals by value

Chapter 4 - Most active diagnostic imaging dealmakers

  • 4.1. Introduction
  • 4.2. Most active diagnostic imaging dealmakers
  • 4.3. Most active diagnostic imaging deals company profiles

Chapter 5 - Diagnostic imaging contracts dealmaking directory

  • 5.1. Introduction
  • 5.2. Diagnostic imaging contracts dealmaking directory

Chapter 6 - Diagnostic imaging dealmaking by technology type

  • Deal directory
  • Deal directory - Diagnostic imaging deals by company A-Z
  • Deal directory - Diagnostic imaging deals by deal type
  • Deal directory - Diagnostic imaging deals by therapy area
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from Current Partnering

Table of figures

  • Figure 1: Diagnostic imaging deals since 2016
  • Figure 2: Active diagnostic imaging dealmaking activity - 2016 - 2023
  • Figure 3: Diagnostic imaging deals by deal type since 2016
  • Figure 4: Diagnostic imaging deals by therapy area since 2016
  • Figure 5: Diagnostic imaging deals by industry sector since 2016
  • Figure 6: Diagnostic imaging deals with a headline value
  • Figure 7: Diagnostic imaging deals with an upfront value
  • Figure 8: Diagnostic imaging deals with a milestone value
  • Figure 9: Diagnostic imaging deals with a royalty rate value
  • Figure 10: Top diagnostic imaging deals by value since 2016
  • Figure 11: Most active diagnostic imaging dealmakers 2016 - 2023
  • Figure 12: Diagnostic imaging deals by technology type since 2016